The Food and Drug Administration is warning people to be on the lookout for counterfeit Ozempic, the diabetes drug that many people use off-label for weight loss. The federal agency and Novo ...

Ozempic is the version of Novo Nordisk's semaglutide drug aimed at people with diabetes. Credit: K KStock/Adobe Stock GLP-1 agonists—such as Ozempic, Mounjaro, and Wegovy—are reshaping the ...